The tumours arising from injected HCC-TGM2 OE cells (vs. inoculated HCC-Mock cells) had a greater mass, accompanied by reduced E-cadherin expression and increased vimentin expression (Fig. 3d). This evidence concerns the gene CDH1 and hepatocellular carcinoma.